Molecules make a Difference

In March 2010 PharmaChemical Ireland launched the first phase of its strategy - “Innovation and Excellence” at the Drugs, Chemical and Allied Products (DCAT) meeting in New York City. At that time the industry recognised real challenges to the future of the sector including how it would respond to the patent cliff. Now as we launch phase four of this strategy we can reflect on how the industry has changed and indeed prospered during that period. The evolution of a thriving Biologics sector in the country has led the association to rename itself- “BioPharmaChem Ireland” – a more accurate description of the range of sectors operating in the country.
logo - Twitter